Nature study finds UNC13A splice correction restored synaptic function in ALS and dementia models
A Nature study reported that experimental antisense molecules correcting UNC13A splicing restored synaptic function in human neuron and mouse models of TDP-43-related disease.
Researchers reported that loss of TDP-43 impaired synaptic communication in human neurons, and that correcting a related UNC13A splicing error reversed those deficits in laboratory models.
The work tested splice-switching antisense oligonucleotides in cultured human neurons and a humanized mouse model. It is preclinical research, not a treatment approval or clinical trial result.